Effect of esophageal cancer screening on mortality among patients with oral cancer and second primary esophageal cancer in Taiwan

被引:3
作者
Chen, Yi-Hsun [1 ]
Ho, Chi-Mei [2 ]
Wu, Meng-Shieh [3 ]
Hsu, Wen-Hung [1 ,4 ]
Wang, Winnie Yen-Yun [5 ,6 ,7 ,8 ]
Yuan, Shyng-Shiou F. [6 ,7 ,8 ,9 ,10 ,11 ,12 ]
Hsieh, Hui-Min [2 ,13 ,14 ,15 ,16 ]
Wu, I-Chen [1 ,4 ,17 ]
机构
[1] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Gastroenterol, 100, Tzyou 1st Rd, Kaohsiung 80756, Taiwan
[2] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Div Gastroenterol, 68 Jhonghua 3rd Rd, Kaohsiung 80145, Taiwan
[4] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Med, 100 Tzyou 1st Rd, Kaohsiung 80756, Taiwan
[5] Kaohsiung Med Univ, Coll Dent Med, Sch Dent, Kaohsiung, Taiwan
[6] Kaohsiung Med Univ Hosp, Translat Res Ctr, Kaohsiung, Taiwan
[7] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan
[8] Kaohsiung Med Univ, Ctr Canc Res, Kaohsiung, Taiwan
[9] Kaohsiung Med Univ Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan
[10] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan
[11] Natl Chiao Tung Univ, Coll Biol Sci & Technol, Dept Biol Sci & Technol, Hsinchu, Taiwan
[12] Natl Chiao Tung Univ, Ctr Intelligent Drug Syst & Smart Biodevices, Hsinchu, Taiwan
[13] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan
[14] Kaohsiung Med Univ Hosp, Dept Community Med, Kaohsiung, Taiwan
[15] Kaohsiung Med Univ, Ctr Big Data Res, Kaohsiung, Taiwan
[16] Kaohsiung Med Univ, Res Ctr Precis Environm Med, Kaohsiung, Taiwan
[17] Kaohsiung Med Univ, Ctr Canc Res, 100 Tzyou 1st Rd, Kaohsiung 80756, Taiwan
关键词
Oral cavity caner; Esophageal cancer; Endoscopic screening; Comparative effectiveness; NECK-CANCER; HEAD; ENDOSCOPY;
D O I
10.1016/j.amjoto.2023.103856
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: Oral and esophageal cancer are the fourth and fifth leading causes of cancer deaths among men in Taiwan. Despite a good prognosis for oral cavity cancer patients, survival is worse for those who develop second primary esophageal cancer. There remains no consensus regarding early prevention of potential second primary esophageal cancer in patients with oral cavity cancer. Our study aimed to compare 5-year mortality between endoscopically screened and non-screened patients with oral cavity cancer and second primary esophageal cancer.Materials and methods: This study identified patients with incident oral cavity cancer and second primary esophageal cancer during 2004 and 2013 using the Taiwan Cancer Registry and National Health Insurance Research Database. We compared 5-year mortality from the second primary esophageal cancer diagnosis date between screened and non-screened groups of patients with oral cavity cancer and second primary esophageal cancer.Results: A total of 217 screened and 305 non-screened oral cavity cancer patients with second primary esophageal cancer were studied. Endoscopic screening significantly improved early detection of second primary esophageal cancer (adjusted odds ratio: 0.34, 95 % confidence interval [CI]: 0.23-0.49) and reduced all-cause mortality (adjusted hazard ratio: 0.80; 95 % CI: 0.66-0.98).Conclusions: Oral cavity cancer patients with second primary esophageal cancer may have worse overall survival than those without. Early detection of second primary esophageal cancer is a crucial mediator between endoscopic screening and mortality. Endoscopic screening after the diagnosis of incident oral cavity cancer significantly increased early detection and reduced all-cause mortality.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Esophageal strictures, tumors, and fistulae: stents for primary esophageal cancer
    Conio, Massimo
    De Ceglie, Antonella
    Blanchi, Sabrina
    Fisher, Deborah A.
    TECHNIQUES IN GASTROINTESTINAL ENDOSCOPY, 2010, 12 (04) : 191 - 202
  • [42] Prognostication for patients with esophageal cancer
    Law, Simon
    ESOPHAGUS, 2009, 6 (04) : 215 - 219
  • [43] Prognostication for patients with esophageal cancer
    Simon Law
    Esophagus, 2009, 6 : 215 - 219
  • [44] Clinical application of oral meglumine diatrizoate esophagogram in screening esophageal fistula during radiotherapy for esophageal cancer
    Geng, Lidan
    Wu, Rong
    Hu, He
    Zhao, Yu
    Fan, Lingli
    Zhao, Zhenhua
    Liao, Dongbiao
    Li, Musheng
    Xiang, Miao
    Ma, Ying
    Du, Xiaobo
    MEDICINE, 2018, 97 (18)
  • [45] Endoscopic Esophageal Tumor Length A Prognostic Factor for Patients With Esophageal Cancer
    Gaur, Puja
    Sepesi, Boris
    Hofstetter, Wayne L.
    Correa, Arlene M.
    Bhutani, Manoop S.
    Watson, Thomas J.
    Swisher, Stephen G.
    CANCER, 2011, 117 (01) : 63 - 69
  • [46] The benefit of pretreatment esophageal screening with image-enhanced endoscopy on the survival of patients with hypopharyngeal cancer
    Wang, Wen-Lun
    Wang, Cheng-Ping
    Wang, Hsiu-Po
    Lee, Ching-Tai
    Chang, Chi-Yang
    Tai, Chi-Ming
    Tseng, Cheng-Hao
    Hwang, Tzer-Zen
    Wang, Chih-Chun
    Lo, Jo-Lin
    Tseng, Ping-Huei
    Chiu, Han-Mo
    Lee, Jang-Ming
    Ko, Jenq-Yuh
    Lou, Pei-Jen
    Wu, Ming-Shiang
    Lee, Yi-Chia
    Lin, Jaw-Town
    ORAL ONCOLOGY, 2013, 49 (08) : 808 - 813
  • [47] Second-line therapy for esophageal cancer
    Martin, Mike G.
    Govindan, Ramoswamy
    Morgensztern, Daniel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (06) : 871 - 876
  • [48] Multimodal treatment for esophageal cancer patients with multiple primary cancers
    Nakamura, Tsutomu
    Udagawa, Harushi
    Aoyama, Norio
    Muro, Kei
    ESOPHAGUS, 2010, 7 (02) : 131 - 131
  • [50] Survival outcomes in esophageal cancer patients with a prior cancer
    Pan, Deqiang
    Xu, Wenbo
    Gao, Xingcai
    Feng Yiyang
    Wei, Shuai
    Zhu, Guang
    MEDICINE, 2021, 100 (07) : E24798